Latest Supply Chain Issues News

Compumedics reported a record $60.3 million in FY26 revenue, driven by an 18% year-on-year increase and a 70% jump in SaaS recurring revenues from Somfit and Nexus 360. The company resolved supply chain disruptions and targets faster EBITDA growth in FY27.

Emeco Holdings expects FY26 operating EBITDA near $290 million despite weather and supply headwinds, while FY27 outlook targets stable earnings with improved utilisation and ongoing deleveraging.

The a2 Milk Company (ASX:A2M) has denied any undisclosed material information following a sharp share price drop and increased trading volumes, attributing market moves to a recent analyst downgrade citing supply chain uncertainties.

a2 Milk confirms no undisclosed information behind recent share price moves, attributing volatility to a CLSA downgrade citing supply delays and previously disclosed risks.

Schoolblazer Limited delivers its inaugural consolidated results following a strategic pivot to global schoolwear, posting $55.3 million revenue but a $15.2 million statutory loss amid integration and supply chain challenges.

Synlait Milk has obtained waivers from its syndicated banks on key financial covenants for the quarter ending April 2026, reflecting ongoing operational and market challenges.

SenSen Networks reported a 17% increase in annual recurring revenue to $11 million and positive operating cash flow of $0.9 million in Q3 FY26 despite supply chain disruptions delaying some projects. The company’s full-year EBITDA is expected to improve significantly over FY25.

Worley Limited reveals the ongoing Middle East conflict is causing significant project delays and an estimated $30 to $40 million hit to FY26 underlying EBITA, prompting a revision to its growth outlook.

Ramelius Resources (ASX: RMS) reported gold production of 38,093 ounces for the March 2026 quarter, maintaining FY26 guidance at the midpoint. The company progressed key projects including early Never Never ore delivery and completed A$110.2 million in share buybacks.

AML3D has landed a AU$2.61 million contract to produce critical submarine components for the US Navy using its advanced 3D metal printing technology, marking a significant step in its US defence expansion.

TerraCom Limited reported a stable operational quarter despite logistical challenges impacting coal shipments and cash flow, while successfully raising A$60 million to bolster liquidity. The Blair Athol mine life was extended to 2033, underpinning the company’s long-term outlook.

Chimeric Therapeutics reports encouraging clinical progress in its CAR-T and NK cell therapy trials, alongside FDA orphan drug designation and a strategic funding boost to propel development.